While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.
23hon MSN
Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback